Related Experiment Video
Updated: Feb 5, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives as new multi-targeted inhibitors of Aurora A/B and KDR
Qiumeng Zhang1, Qianqian Shen2, Lixin Gao3
1Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai, 200062, PR China; National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China.
Abstract:
Aurora A, Aurora B and Kinase Insert Domain-containing Receptor (KDR) play essential roles in sustained cancer growth. In the present study, eighteen pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives were designed and synthesized. Most of the prepared compounds exhibited obviously enzymatic (Aurora A/B and KDR) activities. Among these analogs, compound 17g displayed significant Aurora A/B and KDR potencies with IC50 values of 46.2 nM, 37.6 nM and 21.6 nM, respectively. The results of further biological assays showed that compound 17g possessed moderate anti-proliferative activities against SNU-5, MKN-45 and MKN-74 cells lines, induced G2/M cell cycle arrest and apoptosis in MKN-45, MKN-74, SGC-7901 and SNU-5 cell lines, provided acceptable pharmacokinetic profiles (F = 63.8%), and inhibited the proliferation of SNU-5 tumors in vivo of mice. All of the above results suggested that pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine could be developed as a promising scaffold of multiple Aurora A/B and KDR inhibitors and 17g was worth of further research as a multi-targeted lead compound.
Insights
New pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives show potent inhibition of Aurora A/B and KDR kinases, crucial for cancer growth. Compound 17g, a promising multi-targeted lead, warrants further investigation.
Area of Science:
- Medicinal Chemistry
- Oncology
- Pharmacology
Background:
- Aurora A, Aurora B, and Kinase Insert Domain-containing Receptor (KDR) are key targets in sustained cancer growth.
- Developing novel inhibitors against these targets is crucial for effective cancer therapy.
Purpose of the Study:
- To design and synthesize novel pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives.
- To evaluate the enzymatic activities of these derivatives against Aurora A/B and KDR.
- To assess the anti-proliferative and pharmacokinetic properties of promising compounds.
Main Methods:
- Synthesis of eighteen pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives.
- In vitro enzymatic assays to determine IC50 values against Aurora A/B and KDR.
- Cell-based assays for anti-proliferative activity, cell cycle arrest, and apoptosis.
- In vivo studies to evaluate tumor inhibition and pharmacokinetic profiles.
Main Results:
- Most synthesized compounds demonstrated significant Aurora A/B and KDR inhibitory activities.
- Compound 17g exhibited potent inhibition with IC50 values of 46.2 nM (Aurora A), 37.6 nM (Aurora B), and 21.6 nM (KDR).
- Compound 17g showed moderate anti-proliferative effects, induced G2/M cell cycle arrest and apoptosis, possessed good pharmacokinetics (63.8% bioavailability), and inhibited tumor growth in vivo.
Conclusions:
- The pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine scaffold is a promising foundation for developing multi-targeted inhibitors of Aurora A/B and KDR.
- Compound 17g is a potential lead compound for further preclinical development due to its potent multi-targeted activity and favorable biological profile.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Benzene to 1,4-Cyclohexadiene: Birch Reduction Mechanism
Electrophilic 1,2- and 1,4-Addition of X2 to 1,3-Butadiene
Electrophilic 1,2- and 1,4-Addition of HX to 1,3-Butadiene
Conjugate Addition (1,4-Addition) vs Direct Addition (1,2-Addition)
Conjugate addition results in a thermodynamically stable product. The reaction retains the stronger C=O bond at the expense of the weaker C=C π bond. The process is slow as the β carbon is less electrophilic than the carbonyl carbon.
Direct addition products are...
Multi-input and Multi-variable systems
In the absence of...

